Feasibility of Implementing a Pharmacist-Integrated Collaborative Model for Opioid Use Disorder: A Nonrandomized Clinical Trial - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessing the Feasibility of a Pharmacist-Integrated Collaborative Care Model for Opioid Use Disorder: A Nonrandomized Clinical Trial

  • By

  • Felicity Homsted

  • David A. Fiellin

  • Udi E. Ghitza

  • Vernon T. Gardner

  • Bethany McLeman

  • Paul J. Joudrey

  • Gerald Cochran

  • Sarah K. Moore

  • Lisa Saldana

  • Edward Chongsi

  • Kimberly Kramer

  • Ashley Vena

  • Rebecca A. Ottesen

  • Jacklyn Harris

  • Jesse S. Boggis

  • Deepika Rao

  • Owen Murray

  • Scott Gerlach

  • Phoebe Gauthier

  • Katie P. Osterhage

  • Laura-Mae Baldwin

  • Lisa A. Marsch

  • October 14, 2026

Share

  • 1

    PrIMO integrates pharmacists into primary care teams to support medication treatment for opioid use disorder.

  • 2

    The model includes six core components, including weekly clinical huddles, provider and patient education, comorbidity screening, and education for local partners.

  • 3

    A nonrandomized, mixed-methods feasibility and implementation trial studied PrIMO at four primary care sites in the Northeast, Midwest, Northwest, and Southwest.

  • 4

    The primary feasibility indicator was whether a site launched PrIMO, which signified implementation capacity rather than completion of milestones in sequence.

  • 5

    The study assessed acceptability through staff and patient surveys, and its limited duration precluded a true assessment of sustainability.

Original Source(s)

Feasibility of Implementing a Pharmacist-Integrated Collaborative Model for Opioid Use Disorder: A Nonrandomized Clinical Trial

  • by Felicity Homsted, David A. Fiellin, Udi E. Ghitza, Vernon T. Gardner, Bethany McLeman, Paul J. Joudrey, Gerald Cochran, Sarah K. Moore, Lisa Saldana, Edward Chongsi, Kimberly Kramer, Ashley Vena, Rebecca A. Ottesen, Jacklyn Harris, Jesse S. Boggis, Deepika Rao, Owen Murray, Scott Gerlach, Phoebe Gauthier, Katie P. Osterhage, Laura-Mae Baldwin, Lisa A. Marsch

  • October 14, 2026

Related Content

Skin odor signatures may shift with age

Investigators linked distinct odor patterns to life stage, sex, and skin microbes, while limited longitudinal evidence leaves their clinical utility uncertain.

Early Adoption and Diffusion of Oral Semaglutide in US Adults With Obesity

Gender-Affirming Medical Treatment Prevalence, Decision Satisfaction, and Future Need Among Transgender Adults